Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Oct 06, 2023 (filed on Oct 06, 2023)Insider Name:Goldman Sachs Group IncOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Yale Kenneth P.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:502,404Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Somerman Martha J. DDS, PhDOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:518,429Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Roper JessOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:512,821Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:OLoughlin Kathleen TOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:502,404Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Summerhays Carol Gomez DDSOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:491,987Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Lord Jonathan T MdOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:721,154Price:--
-
Jun 02, 2023 (filed on Jun 06, 2023)Insider Name:Sandor StevenOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:58,000Price:--
-
Jun 02, 2023 (filed on Jun 06, 2023)Insider Name:Bright JenniferOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:58,000Price:--
-
Jun 02, 2023 (filed on Jun 06, 2023)Insider Name:Bright JenniferOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:58,000Price:--
Filings by filing date
-
Oct 06, 2023 (filed on Oct 06, 2023)Insider Name:Goldman Sachs Group IncOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:Form 3 : Initial Statement of Beneficial Ownership of Securities# or value acquired/disposed of:--Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Yale Kenneth P.Ownership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:502,404Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Somerman Martha J. DDS, PhDOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:518,429Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Roper JessOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:512,821Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:OLoughlin Kathleen TOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:502,404Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Summerhays Carol Gomez DDSOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:491,987Price:--
-
Jun 08, 2023 (filed on Jun 12, 2023)Insider Name:Lord Jonathan T MdOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:721,154Price:--
-
Jun 02, 2023 (filed on Jun 06, 2023)Insider Name:Sandor StevenOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:58,000Price:--
-
Jun 02, 2023 (filed on Jun 06, 2023)Insider Name:Bright JenniferOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:58,000Price:--
-
Jun 02, 2023 (filed on Jun 06, 2023)Insider Name:Bright JenniferOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:58,000Price:--
News
Biz Brief
Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 27042 Towne Centre Drive, Suite 270 FOOTHILL RANCH CA 92610 |
Tel: | 1-732-9332754 |
Website: | https://www.biolase.com |
IR: | See website |
Key People | ||
John R. Beaver President, Chief Executive Officer, Director | Jennifer Bright Chief Financial Officer | Steven Sandor Chief Operating Officer |
Business Overview |
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse. |
Financial Overview |
For the fiscal year ended 31 December 2023, BIOLASE Inc revenues increased 1% to $49.2M. Net loss applicable to common stockholders increased 30% to $37.6M. Revenues reflect Consumables and other segment increase of 20% to $13.6M, International segment increase of 5% to $15.3M, United States segment remaining flat at $33.9M. Basic Earnings per Share excluding Extraordinary Items increased from -$416.32 to -$29.44. |
Employees: | 157 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $14.47M as of Dec 31, 2023 |
Annual revenue (TTM): | $49.16M as of Dec 31, 2023 |
EBITDA (TTM): | -$15.10M as of Dec 31, 2023 |
Net annual income (TTM): | -$37.62M as of Dec 31, 2023 |
Free cash flow (TTM): | -$15.40M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | $7.48M as of Dec 31, 2023 |
Shares outstanding: | 33,256,943 as of Mar 27, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |